Effect of Punarnavadi Kwath and Varunadi Kwath In The Management Of Mutravaha Sarotodushti ( Chronic Kidney Disesase )
- Conditions
- Chronic kidney disease (CKD). Ayurveda Condition: MUTRAVAHASROTODUSHTIH,
- Registration Number
- CTRI/2021/04/033218
- Lead Sponsor
- National Institute Ayurveda Jaipur
- Brief Summary
AIMSAND OBJECTIVES:
qTo evaluate and compare the clinicalefficacy of “Punarnavadi Kwatha†and “Varunadi Kwatha†in the management of Mutravaha Srotodushti w.s.r to Chronic Kidney Disease.
NEED OFSTUDY:
qRetarding the progression of renalfailure is one of the most important task of the nephrologist as it not onlyinvolves the quality of life of patient but also delays the development of endstage renal diseases, use of dialysis, transplantation cause financial burdento patient.
q Varunadi Kwatha seem to be helpful to relieve the Kapha and Vata Dosha and Punarnavadi Kwatha has Rasayan properties for Mutravaha Srotas which can prevent and repaired a tissuedamage.
q After reviewing the literature andkeeping in mind the Dosha- Dushya of Mutravaha Srotodusti, Punarnavadi Kwath and Varunadi Kwatha has been chosen for the study as thesedrugs possess above mentioned properties.
HYPOTHESIS:
NULLHYPOTHESIS:
There is nosignificance difference between the effect of trial drug ( PunarnavadiKwathand Varunadi Kwath)
ALTERNATIVEHYPOTHESIS:
There is a significant difference between theeffect of trial drugs (Punarnavadi Kwathand Varunadi Kwatha)in the managementof Mutravaha Srotodushti.
STUDYDRUGS
A.PunaranavadiKwath( KalpitYoga )
B.VarunadiKwath( BhavaprakashaChi.37/12 )
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
1 Patient willing to participate in clinical trial 2 Patients having any clinical signs and symptoms of chronic renal failure 3 Patients with Hypertension <160/100 mm of hg 4 Patients of Serum creatinine level 1.2 to 5.0 mg/dl 5 Patients of Blood urea level 40 to 150 mg/dl.
- 1 Age: below 21 years and above 59 years 2 Patients having other associated disease like congenital disease Myeloma, Neoplasm etc.
- 3 Patient participated in any clinical trial with in last six months.
- 4 Pregnant or lactating women.
- 5 Familial or hereditary kidney disease, e.g. Polycystic kidney.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the clinical symptoms of Mutravaha Srotodushti (Chronic Kidney Disease). 30 Days
- Secondary Outcome Measures
Name Time Method Changes in the objective parameters. 30 Days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
National Institute of Ayurveda and Hospital
🇮🇳Jaipur, RAJASTHAN, India
National Institute of Ayurveda and Hospital🇮🇳Jaipur, RAJASTHAN, IndiaDr Karan Prakash SharmaPrincipal investigator8239225104kpsayurvedh024@gmail.com